PacificGMP and VasGene Therapeutics Inc. Announce Successful Manufacture of Recombinant Fusion Protein for Phase 1 Clinical Trial
6/7/2012 9:40:46 AM
More...
|
Hybridon, Inc. (HBY) Reports 2004 Financial Results
10/19/2005 5:13:07 PM
More...
|
VasGene Therapeutics Inc. Release: Veglin Phase I Trial Shows Potential In Fighting Angiogenesis And Tumor Progression
10/19/2005 5:11:38 PM
More...
|
VasGene Therapeutics Inc. Release: Findings Of Next-Generation VEGF Cancer Agent Presented At American Society of Hematology (ASH); Norris-USC Team Presents Data At ASH From Phase I Trial In Relapsed And Refractory Malignancies At ASH
10/19/2005 5:09:28 PM
More...
|
MedImmune, Inc. (MEDI) And VasGene Therapeutics Inc. Announce Collaboration To Develop Monoclonal Antibodies Targeting Cancer
10/19/2005 5:09:15 PM
More...
|